Abiopharma

🔍 TANNENBAUM LEONARD M (Director)

Company: Advanced Flower Capital Inc. (AFCG)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 29,040 shares of Common Stock at $2.76 per share (Direct)
  Date: 2026-03-31 | Code: P | equity_swap_involved: 0 | shares_owned_after: 6,426,175.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: Held by spouse | shares_owned_after: 225,907.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 180,400.00 | Footnotes: F3

Footnotes:

• F1: This transaction was executed in multiple trades ranging from $2.67 to $2.81; the price reported reflects the weighted average price. The Reporting Person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or any security holder of the issuer.
• F2: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
• F3: These shares are held by the Tannenbaum Family Foundation (formerly known as the Leonard M. Tannenbaum Foundation), for which the Reporting Person serves as the President. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.